Egypt’s stock market ended the first week of February on a mixed note, signalling a shift from January’s broad rally toward a more selective, stock-picking environment. The Egyptian Exchange held close to record territory, but gains became more measured as investors reassessed valuations and rotated across sectors.
By Thursday’s close, the EGX30 edged up 0.22% to 49,739.03 points, supported by steady demand for heavyweight stocks. Shariah-compliant shares outperformed, with the EGX33 rising 0.43%, while the EGX35-LV was broadly flat. In contrast, broader indices softened slightly, as the EGX70 and EGX100 posted marginal declines, reflecting continued profit-taking in small- and mid-cap stocks after January’s sharp gains.
Despite the mixed index performance, market capitalisation climbed to around EGP 3.25 trillion, highlighting the scale of value added since the start of the year. Trading flows were notably supportive: Arab and non-Arab foreign investors remained net buyers, while Egyptian investors also posted net purchases—an uncommon alignment that helped stabilise the market at elevated levels.
Stock-level moves underlined the selective tone. Egypt for Poultry led gainers with a 12.5% rise, while Ibnsina Pharma advanced 8.1%, reinforcing continued interest in consumer and healthcare names. On the downside, Raya Holding, Alexandria National Company for Financial Investment, and Prime Holding saw declines of between 4–5%, as investors trimmed exposure to previously strong financial stocks.
Overall, the week confirmed that the EGX is consolidating rather than reversing. Foreign inflows, solid liquidity, and improving market depth continue to underpin sentiment, but advances are increasingly driven by fundamentals rather than momentum. For investors, early February marked a transition to a more disciplined phase—one where earnings visibility, balance-sheet strength, and sector positioning matter more than broad market exposure.
